Faeth Therapeutics Q3 EPS $(0.79) Misses $(0.71) Estimate

Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.71) by 11.27 percent. This is a 78.18 percent increase over losses of $(3.62) per share from the same period last year.